SRPT
SRPT
US8036071004
Sarepta Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 2.198.237.000 1.901.979.000
15.6%
Cost of Revenue 839.605.000 319.099.000
163.1%
Gross Profit 1.358.632.000 1.582.880.000
14.2%
2.016.404.000 1.364.799.000
47.7%
Operating Income -657.772.000 218.081.000
401.6%
Pretax Income -702.225.000 260.774.000
369.3%
Net Income Common Stockholders -713.410.000 235.239.000
403.3%
-- --
--
-- --
--
ende